NASDAQ : TNGX
Tango Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 21.91 USD (Oct 30, 2026, 3:18 PM EDT) · Market cap 3.69B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Tango Therapeutics, Inc. (TNGX) reported revenue of 53.81M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 53.81M | 62.38M | 42.07M | 36.53M | 24.86M | 37.04M |
| Cost of Revenue | 133.65M | 132.16M | 143.92M | 115.20M | 105.91M | 77.64M |
| Gross Profit | -79.84M | -69.78M | -101.85M | -78.67M | -81.05M | -40.59M |
| Selling, General & Admin | 56.51M | 41.51M | 43.75M | 35.50M | 30.02M | 17.60M |
| Operating Expenses | 56.51M | 41.51M | 43.75M | 35.50M | 30.02M | 17.60M |
| Operating Income | -136.35M | -111.29M | -145.59M | -114.17M | -111.07M | -58.19M |
| Interest & Investment Income | 8.68M | 5.63M | 7.89M | 6.62M | 1.46M | 495.00K |
| Other Non Operating Income (Expenses) | 3.18M | 4.07M | 7.61M | 5.94M | 1.49M | -248.00K |
| Pretax Income | -123.78M | -101.59M | -130.09M | -101.61M | -108.12M | -57.94M |
| Income Tax Expense | -63.00K | 4.00K | 208.00K | 134.00K | 54.00K | 292.00K |
| Net Income | -123.72M | -101.59M | -130.30M | -101.74M | -108.18M | -58.23M |
| Net Income to Common | -123.72M | -101.59M | -130.30M | -101.74M | -108.18M | -58.23M |
| Shares Outstanding (Basic) | 135.25M | 116.17M | 109.23M | 94.57M | 87.82M | 62.11M |
| Shares Outstanding (Diluted) | 135.25M | 116.17M | 109.23M | 94.57M | 87.82M | 62.11M |
| EPS (Basic) | -0.91 | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| EPS (Diluted) | -0.91 | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| Free Cash Flow | -144.27M | -139.93M | -132.25M | -119.51M | -116.77M | -61.36M |
| Free Cash Flow Per Share | -1.07 | -1.21 | -1.21 | -1.26 | -1.33 | -0.99 |
| Gross Margin | -148.37% | -111.86% | -242.10% | -215.38% | -109.59% | |
| Operating Margin | -253.38% | -178.39% | -346.09% | -312.57% | -446.79% | -157.09% |
| Profit Margin | -229.92% | -162.85% | -309.73% | -278.55% | -435.14% | -157.21% |
| Free Cash Flow Margin | -268.10% | -224.31% | -314.38% | -327.18% | -469.72% | -165.66% |
| EBITDA | -134.43M | -109.01M | -143.10M | -111.76M | -109.46M | -57.29M |
| EBITDA Margin | -249.81% | -174.74% | -154.67% | |||
| D&A For EBITDA | 1.92M | 2.28M | 2.50M | 2.42M | 1.61M | 897.00K |
| EBIT | -136.35M | -111.29M | -145.59M | -114.17M | -111.07M | -58.19M |
| EBIT Margin | -253.38% | -178.39% | -157.09% | |||
| Revenue as Reported | 62.38M | 62.38M | 42.07M | 36.53M | 24.86M | 37.04M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 345.56M | 112.28M | 69.53M | 66.39M | 59.97M | 142.75M |
| Short-Term Investments | 668.43M | 230.86M | 188.39M | 270.50M | 306.17M | 342.51M |
| Cash & Short-Term Investments | 1.01B | 343.14M | 257.92M | 336.88M | 366.13M | 485.25M |
| Receivables | 2.00M | 2.00M | ||||
| Prepaid Expenses | 17.68M | 10.19M | 8.43M | 8.80M | 6.57M | 4.52M |
| Restricted Cash | 428.00K | 856.00K | 567.00K | 567.00K | ||
| Total Current Assets | 1.03B | 353.76M | 266.34M | 346.54M | 375.27M | 492.34M |
| Property, Plant & Equipment | 39.76M | 42.49M | 47.58M | 53.42M | 57.77M | 6.09M |
| Long-Term Investments | 500.00K | |||||
| Other Long-Term Assets | 2.45M | 1.94M | 2.57M | 2.61M | 3.43M | 1.73M |
| Total Assets | 1.07B | 398.69M | 316.49M | 402.57M | 436.47M | 500.15M |
| Accounts Payable | 1.81M | 1.18M | 1.60M | 2.79M | 4.45M | 3.23M |
| Accrued Expenses | 12.71M | 16.47M | 14.76M | 14.11M | 16.23M | 9.22M |
| Current Portion of Leases | 2.94M | 2.74M | 2.45M | 2.08M | 1.77M | 1.50M |
| Current Income Taxes Payable | 35.00K | 52.00K | ||||
| Current Unearned Revenue | 17.62M | 25.67M | 31.79M | 26.02M | ||
| Other Current Liabilities | 2.83M | 1.29M | 1.74M | 1.29M | 1.27M | 666.00K |
| Total Current Liabilities | 20.30M | 21.68M | 38.17M | 45.94M | 55.55M | 40.69M |
| Long-Term Leases | 29.05M | 30.83M | 34.04M | 36.84M | 39.36M | |
| Long-Term Unearned Revenue | 44.77M | 66.68M | 92.09M | 114.72M | ||
| Total Liabilities | 49.35M | 52.51M | 116.97M | 149.46M | 186.99M | 155.41M |
| Common Stock | 168.00K | 136.00K | 108.00K | 102.00K | 88.00K | 88.00K |
| Additional Paid-In Capital | 1.73B | 948.97M | 700.63M | 624.08M | 522.61M | 506.76M |
| Retained Earnings | -704.01M | -603.15M | -501.56M | -371.26M | -269.51M | -161.34M |
| Comprehensive Income & Other | -633.00K | 224.00K | 336.00K | 186.00K | -3.71M | -765.00K |
| Total Common Equity | 1.02B | 346.18M | 199.52M | 253.11M | 249.48M | 344.75M |
| Shareholders' Equity | 1.02B | 346.18M | 199.52M | 253.11M | 249.48M | 344.75M |
| Total Liabilities & Equity | 1.07B | 398.69M | 316.49M | 402.57M | 436.47M | 500.15M |
| Total Debt | 31.99M | 33.57M | 36.49M | 38.92M | 41.13M | 1.50M |
| Net Cash (Debt) | 982.00M | 309.57M | 221.42M | 297.96M | 325.00M | 483.75M |
| Net Cash Per Share | 7.26 | 2.66 | 2.03 | 3.15 | 3.70 | 7.79 |
| Filing Date Shares Outstanding | 168.61M | 142.69M | 108.11M | 106.72M | 88.20M | 87.71M |
| Total Common Shares Outstanding | 168.38M | 135.94M | 107.73M | 102.20M | 88.18M | 87.60M |
| Working Capital | 1.01B | 332.08M | 228.17M | 300.60M | 319.73M | 451.65M |
| Book Value Per Share | 6.08 | 2.55 | 1.85 | 2.48 | 2.83 | 3.94 |
| Tangible Book Value | 1.02B | 346.18M | 199.52M | 253.11M | 249.48M | 344.75M |
| Tangible Book Value Per Share | 6.08 | 2.55 | 1.85 | 2.48 | 2.83 | 3.94 |
| Machinery | 13.39M | 13.56M | 13.32M | 12.88M | 11.65M | 6.25M |
| Construction In Progress | 140.00K | 152.00K | 38.00K | 8.00K | 738.00K | |
| Leasehold Improvements | 3.72M | 3.72M | 2.87M | 2.86M | 2.78M | 246.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -123.72M | -101.59M | -130.30M | -101.74M | -108.18M | -58.23M |
| Depreciation & Amortization | 1.92M | 2.28M | 2.50M | 2.42M | 1.61M | 897.00K |
| Loss (Gain) From Sale of Investments | -3.40M | -2.69M | -4.62M | -3.39M | ||
| Stock-Based Compensation | 40.29M | 26.43M | 28.90M | 19.08M | 14.23M | 7.83M |
| Other Operating Activities | 3.87M | 3.88M | 3.77M | 3.63M | 1.75M | 1.32M |
| Change in Accounts Receivable | 2.00M | |||||
| Change in Accounts Payable | -549.00K | -825.00K | -1.18M | -1.71M | 1.10M | 1.23M |
| Change in Unearned Revenue | -53.81M | -62.38M | -29.97M | -31.53M | -16.86M | -12.04M |
| Change in Other Net Operating Assets | -8.51M | -3.99M | -593.00K | -6.73M | -2.73M | -535.00K |
| Operating Cash Flow | -143.90M | -138.89M | -131.50M | -117.98M | -109.08M | -59.53M |
| Capital Expenditures | -373.00K | -1.05M | -754.00K | -1.53M | -7.69M | -1.84M |
| Investment in Securities | -524.23M | -39.82M | 86.88M | 42.95M | 34.09M | -181.60M |
| Investing Cash Flow | -524.58M | -40.87M | 86.13M | 41.43M | 26.40M | -183.43M |
| Issuance of Common Stock | 975.00M | 222.54M | 47.66M | 82.65M | 1.62M | 1.06M |
| Other Financing Activities | -668.00K | -36.00K | -241.00K | -8.00K | 326.28M | |
| Financing Cash Flow | 974.33M | 222.50M | 47.66M | 82.41M | 1.61M | 357.32M |
| Net Cash Flow | 305.86M | 42.75M | 2.29M | 5.85M | -81.07M | 114.36M |
| Free Cash Flow | -144.27M | -139.93M | -132.25M | -119.51M | -116.77M | -61.36M |
| Free Cash Flow Margin | -268.10% | -224.31% | -314.38% | -327.18% | -469.72% | -165.66% |
| Free Cash Flow Per Share | -1.07 | -1.21 | -1.21 | -1.26 | -1.33 | -0.99 |
| Levered Free Cash Flow | -71.87M | -60.86M | -67.27M | -61.82M | -48.74M | -34.02M |
| Unlevered Free Cash Flow | -71.87M | -60.86M | -67.27M | -61.82M | -48.74M | -34.02M |
| Change in Working Capital | -62.87M | -67.20M | -31.75M | -37.97M | -18.49M | -11.35M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.67B | 1.19B | 331.92M | 1.01B | 639.29M | 957.76M |
| Enterprise Value | 2.69B | 1.08B | 76.27M | 689.32M | 286.72M | 461.13M |
| Last Close Price | 22.72 | 8.86 | 3.09 | 9.90 | 7.25 | 10.94 |
| PS Ratio | 69.50 | 19.13 | 7.89 | 27.64 | 25.71 | 25.86 |
| PB Ratio | 3.73 | 3.45 | 1.66 | 3.99 | 2.56 | 2.78 |
| P/TBV Ratio | 3.65 | 3.45 | 1.66 | 3.99 | 2.56 | 2.78 |
| EV/Sales Ratio | 51.25 | 17.23 | 1.81 | 18.87 | 11.53 | 12.45 |
| Debt / Equity Ratio | 0.03 | 0.10 | 0.18 | 0.15 | 0.17 | 0.00 |
| Net Debt / Equity Ratio | -0.96 | -0.89 | -1.11 | -1.18 | -1.30 | -1.40 |
| Net Debt / EBITDA Ratio | 7.30 | 2.84 | 1.55 | 2.67 | 2.97 | 8.44 |
| Net Debt / FCF Ratio | 6.81 | 2.21 | 1.67 | 2.49 | 2.78 | 7.88 |
| Asset Turnover | 0.08 | 0.17 | 0.12 | 0.09 | 0.05 | 0.10 |
| Quick Ratio | 49.95 | 15.83 | 6.76 | 7.33 | 6.63 | 11.97 |
| Current Ratio | 50.82 | 16.32 | 6.98 | 7.54 | 6.76 | 12.10 |
| Return on Equity (ROE) | -21.34% | -37.23% | -57.58% | -40.49% | -36.41% | -30.38% |
| Return on Assets (ROA) | -12.99% | -19.45% | -25.31% | -17.01% | -14.82% | -10.28% |
| Return on Capital Employed (ROCE) | -12.90% | -29.50% | -52.30% | -32.00% | -29.20% | -12.70% |
| Earnings Yield | -4.20% | -8.51% | -39.26% | -10.08% | -16.92% | -6.08% |
| FCF Yield | -3.86% | -11.73% | -39.85% | -11.84% | -18.27% | -6.41% |
| Buyback Yield / Dilution | -22.81% | -6.35% | -15.50% | -7.69% | -41.40% | -94.50% |